Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
This triple mechanism of action distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist)
Month 1 Summary: What Was Accomplished Weight loss: 2-4 pounds average (1-2% of starting weight) Appetite change: 60-70% report noticeable suppression Side effects: Mild to moderate in 40% of people, minimal in 60% Discontinuation rate: 3-5% stop during month 1 (lowest attrition period) Psychological state: Hopeful but impatient for faster results Key achievement: Body adapted to medication without major complications Reality check: Month 1 is the easiest month
Vitamin B12 (Methylcobalamin or Cyanocobalamin): Essential for red blood cell production, neurological health, and energy metabolism
PMID 34959912
Our friendly team will confirm your appointment and send you the clinics exact location
US$ 21.74
US$ 24.04
US$ 27.63
US$ 23.84
